Table 1. Patient Characteristics.
Case | Origin | TNM stage | Diagnosis | Chemotherapy (term) | Ultrasonography | CT | MRI | DWI-MRI | PET-CT |
---|---|---|---|---|---|---|---|---|---|
Arakawa et al. | Rectum | Not mentioned | CRM | XELOX (8 cycles) | Hyperechoic | Hypodense lesion with heterogeneous enhancement | EOB: defect on the hepatocellular phase | None | None |
Uchino et al. | Rectum | T4N1M0 | CRM | mFOLFOX6 (6 cycles) | N.D. | Hypodense lesion | T1: low intensity, T2: high intensity, EOB: defect on the hepatocellular phase | N.D. | None |
Alexandrino et al. | Sigmoid colon, rectum | T3N1M0 | CRM | XELOX (12 cycles) | hypoechoic | Hypodense lesion | None | None | None |
Present case | Liver metastasis | T3N1M1 | CRM | mFOLFOX6 (12 cycles) | Slightly hyperechoic | Hypodense lesion | T1: low intensity, T2: high intensity, EOB: defect on the hepatocellular phase | N.D. | N.D. |
Abbreviations: CRM,colorectal metastasis; DWI, diffusion-weighted image; EOB, gadoxetic acid-enhanced magnetic resonance imaging; N.D., not detected.